Last reviewed · How we verify

Nerve Growth Factors — Competitive Intelligence Brief

Nerve Growth Factors (Nerve Growth Factors) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Neurotrophic factor. Area: Neurology.

marketed Neurotrophic factor TrkA receptor, p75 receptor Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Nerve Growth Factors (Nerve Growth Factors) — Jinling Hospital, China. Nerve Growth Factor (NGF) promotes the survival, growth, and differentiation of nerve cells, enhancing neuronal repair and regeneration.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Nerve Growth Factors TARGET Nerve Growth Factors Jinling Hospital, China marketed Neurotrophic factor TrkA receptor, p75 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Neurotrophic factor class)

  1. Jinling Hospital, China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Nerve Growth Factors — Competitive Intelligence Brief. https://druglandscape.com/ci/nerve-growth-factors. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: